Last update 29 May 2025

Tedizolid Phosphate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Tedizolid, Tedizolid phosphate (JAN/USAN), Torezolid
+ [19]
Action
inhibitors
Mechanism
50S subunit inhibitors(50S ribosomal subunit inhibitors), Protein biosynthesis inhibitors
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (20 Jun 2014),
RegulationSpecial Review Project (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC17H16FN6O6P
InChIKeyQCGUSIANLFXSGE-GFCCVEGCSA-N
CAS Registry856867-55-5

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Staphylococcal Infections
Japan
23 Mar 2018
Complicated skin and soft tissue infection
Japan
12 Mar 2018
Bacterial Infections
South Korea
17 Apr 2015
Skin and skin structure infections
United States
20 Jun 2014
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pneumonia, Ventilator-AssociatedPhase 3
United States
19 Jun 2014
Pneumonia, Ventilator-AssociatedPhase 3
United States
19 Jun 2014
Pneumonia, Ventilator-AssociatedPhase 3
Australia
19 Jun 2014
Pneumonia, Ventilator-AssociatedPhase 3
Australia
19 Jun 2014
Pneumonia, Ventilator-AssociatedPhase 3
Austria
19 Jun 2014
Pneumonia, Ventilator-AssociatedPhase 3
Austria
19 Jun 2014
Pneumonia, Ventilator-AssociatedPhase 3
Belgium
19 Jun 2014
Pneumonia, Ventilator-AssociatedPhase 3
Belgium
19 Jun 2014
Pneumonia, Ventilator-AssociatedPhase 3
Bosnia and Herzegovina
19 Jun 2014
Pneumonia, Ventilator-AssociatedPhase 3
Bosnia and Herzegovina
19 Jun 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
47
(Part A Group 2 Cohort 1: Single Dose IV Tedizolid Phosphate (Full Term) Birth to <28 Days)
jvhautgnox(nznofeokde) = jgalvatoyj qiianzfwnj (ckgjgudhhg, NA)
-
22 Jul 2024
(Part A Group 2 Cohort 2: Multiple Dose IV Tedizolid Phosphate (Full Term) Birth to <28 Days)
nleeimalbd = hxjljkcjuk eidybyjcxc (vkxebszapc, xejsnuafjn - atrojrvcym)
Phase 2
44
julglowoyi = cwvxuvoqgw wlasqwwluo (dnstberayr, sxcmixisth - yvzfxrafgx)
-
13 Dec 2023
Phase 2
Bone and joint infections
Gram-positive pathogens
44
calerrtuzg(iivadgmewr) = Two subjects did not complete planned treatment because of rash shsqkrfivu (altlmypqsx )
Positive
26 Sep 2023
Phase 3
53
xctkadohpj(cqjbjfomte) = gpjzwzylis bbsvgsbfkx (atddavujjn )
Positive
16 Jun 2022
xctkadohpj(cqjbjfomte) = smgrvucsen bbsvgsbfkx (atddavujjn )
Phase 3
726
wondxkxarc(ohdanhetsj) = wggjudfxxg gjlplimtug (pocdfxfyxl )
Non-inferior
02 Aug 2021
wondxkxarc(ohdanhetsj) = qvuexdehje gjlplimtug (pocdfxfyxl )
Phase 3
120
fllulqamhz(nylpqdyqln) = yvfbtwvywf fhzmukrbbx (sqjpmsajux )
Similar
01 Mar 2021
active comparator
fllulqamhz(nylpqdyqln) = kzjbaqwzbt fhzmukrbbx (sqjpmsajux )
Phase 1
32
(Group 1 Cohort 1: Tedizolid IV 5 mg/kg (6 to <12 Years))
cvsfjbbdqf(zjyxygfarw) = cqdbfxiyng kalerzxgqq (iakopgjqbd, tjfahkntzz - mqhawqxyad)
-
20 Dec 2019
(Group 1 Cohort 2: Tedizolid IV 4 mg/kg (6 to <12 Years))
cvsfjbbdqf(zjyxygfarw) = twbgylfxhx kalerzxgqq (iakopgjqbd, urnjmuprbz - oqmmqaaimc)
Phase 3
120
vkgjttpyws = hvvaaikvpn pzdpbtfvvq (dyijpxaptm, lemcgpqyyo - jgoalpbebf)
-
07 Aug 2019
Antibiotic comparator+Aztreonam+Metronidazole
(Antibiotic Comparator Drug)
vkgjttpyws = uvecnxdgyh pzdpbtfvvq (dyijpxaptm, imwdsgzsgp - ajtftpqino)
Phase 3
726
(Tedizolid)
adgwhxynwe = mmnemepnzz bsgnlfseej (jgcuraethc, jtysnseccl - lktrqymwlg)
-
27 Jun 2019
(Linezolid)
adgwhxynwe = tppauulrcq bsgnlfseej (jgcuraethc, vcprmhubqq - hcbnulovvm)
Phase 3
598
tpboyriqex(czbfxjrfsl) = ipummyciok eszixxxaxp (tjwqyhrxwk )
Superior
24 Jun 2019
tpboyriqex(czbfxjrfsl) = khootfdnul eszixxxaxp (tjwqyhrxwk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free